CD38CD8+T

Marie J Y Reolo1, Masayuki Otsuka1, Justine Jia Wen Seow2

  • 1Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, Singapore.

PubMed
概括

CD38是肝细胞癌 (HCC) 中T细胞耗尽的标志物. 它与CD8+T细胞上的耗尽标记的共同表达与HCC的攻击性相关,并表明了治疗点.